[HTML] frontiersin.org

[HTML][HTML] Enhanced human T lymphocyte antigen priming by cytokine-matured dendritic cells overexpressing bcl-2 and IL-12

H Zhang, Y Wang, QT Wang, SN Sun, SY Li… - Frontiers in Cell and …, 2020 - frontiersin.org
Dendritic cell (DC)-based vaccination is a promising immunotherapeutic strategy for cancer.
However, clinical trials have shown only limited efficacy, suggesting the need to optimize …
被引用次数：8 相关文章

Enhanced Human T Lymphocyte Antigen Priming by Cytokine-Matured Dendritic Cells Overexpressing Bcl-2 and IL-12

H Zhang, Y Wang, QT Wang, SN Sun… - Frontiers in cell …, 2020 - pubmed.ncbi.nlm.nih.gov
Dendritic cell (DC)-based vaccination is a promising immunotherapeutic strategy for cancer.
However, clinical trials have shown only limited efficacy, suggesting the need to optimize …

Enhanced Human T Lymphocyte Antigen Priming by Cytokine-Matured Dendritic Cells Overexpressing Bcl-2 and IL-12.

H Zhang, Y Wang, QT Wang, SN Sun, SY Li… - Frontiers in Cell and …, 2020 - europepmc.org
Dendritic cell (DC)-based vaccination is a promising immunotherapeutic strategy for cancer.
However, clinical trials have shown only limited efficacy, suggesting the need to optimize …

Enhanced Human T Lymphocyte Antigen Priming by Cytokine-Matured Dendritic Cells Overexpressing Bcl-2 and IL-12

H Zhang, Y Wang, QT Wang, SN Sun, SY Li, H Shang… - 2020 - agris.fao.org
Dendritic cell (DC)-based vaccination is a promising immunotherapeutic strategy for cancer.
However, clinical trials have shown only limited efficacy, suggesting the need to optimize …
[HTML] nih.gov

[HTML][HTML] Enhanced Human T Lymphocyte Antigen Priming by Cytokine-Matured Dendritic Cells Overexpressing Bcl-2 and IL-12

H Zhang, Y Wang, QT Wang, SN Sun… - Frontiers in Cell and …, 2020 - ncbi.nlm.nih.gov
Dendritic cell (DC)-based vaccination is a promising immunotherapeutic strategy for cancer.
However, clinical trials have shown only limited efficacy, suggesting the need to optimize …